Drugs Manufactured With A Forged License, FIR Lodged, Drugs Worth 23.93 Lakhs Seized

Hyderabad: Drugs Control Administration, Telangana, has detected a significant case of fraudulent activity within the pharmaceutical industry. An investigation conducted by DCA officials has revealed that Ovoid Pharmachem Pvt. Ltd., located at Plot No. 318, Subashnagar, Quthbullapur Mandal, Medchal-Malkajgiri District, engaged in the forgery of a drug manufacturing license.

VB Kamalasan Reddy (IPS), Director General, DCA Telangana said in a press release that “Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., was involved in the creation of a forged Drug Manufacturing license in Form-25, bearing No. TS/MFG2019-43319, L.Dis.No: 315995/TS/2022 dated: 05/07/2022, for certain drug products which were not authorized for the company by the Drugs Control Administration, Telangana. This unlawful activity was carried out with the intention to deceive drug regulatory authorities, pharmaceutical manufacturers, distributors, and the public.

Upon verification of the Drugs Control Administration, Telangana licensing database on the ODLS (Online Drug Licensing System) Portal, it has been confirmed that Ovoid Pharmachem Pvt. Ltd. created a fake drug licence for certain drug products.

DCA also detected that the firm manufactured and sold certain drug products under this fraudulent license. Drugs Control Administration officials seized stocks worth Rs. 23.93 lakhs, including 800 Kgs of Activated Charcoal 250 mg and Simethicone 80 mg Pellets.”

Drugs Control Administration, Telangana, has filed a complaint with the Jeedimetla Police Station. FIR No. 327/2024 has been registered on 05-04-2024 against Mr. Narasapally Ramudu, Director of Ovoid Pharmachem Pvt. Ltd., under Sections 420 (Cheating) and 468 (Forgery) of the Indian Penal Code (IPC).

It is imperative to emphasize that the manufacturing and sale of pharmaceutical products under forged licenses pose a significant threat to public health and safety. All manufacturers shall comply strictly with regulatory requirements and maintain the highest standards of ethical conduct.

Related Posts

  • Pharma
  • May 25, 2024
  • 64 views
NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of asthma inhaler drug combination formoteral 6 mcg and budesonide 400 mcg dry power inhaler (DPI) under…

  • Pharma
  • May 25, 2024
  • 75 views
Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Jaipur: To provide quality education in pharmacy institutes, the central government has prepared to end the duplicate system. Strict action will be taken against fake students and teachers in newly opened…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

A Doctor diagnoses Mood of Voters in Delhi

A Doctor diagnoses Mood of Voters in Delhi

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research